A study points to new therapeutic targets for tumors associated with chronic inflammation

0

(Institute for Research in Biomedicine (IRB Barcelona)) Scientists headed by ICREA researcher Angel R. Nebreda at the Institute for Research in Biomedicine (IRB Barcelona) report a new mechanism that contributes to the development of inflammation-associated colon cancer and points to new therapeutic targets. The study has been published in the journal EMBO Molecular Medicine.

Leave A Reply

Your email address will not be published.